Cholesterol management in patients with heart disease
- 1 August 1997
- journal article
- review article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 102 (2) , 81-90
- https://doi.org/10.3810/pgm.1997.08.292
Abstract
Advances in treatment of elevated cholesterol levels and recent documentation of efficacy and safety in clinical trials justify expanded use of cholesterol-lowering therapy in clinical practice. Patients with CHD or other forms of clinical atherosclerotic disease can benefit from aggressive cholesterol management. Maximal dietary modification, weight control, and physical activity are valuable adjuncts to drug therapy in secondary prevention. Recent studies have shown that appropriate use of cholesterol-lowering drugs is cost-effective and efficacious in patients with CHD. Use of such drugs can increase patients' life expectancy. Primary care physicians have a key role in instituting intensive cholesterol management in patients with clinically manifest atherosclerotic disease. Furthermore, they should take the lead in coordinating with cardiovascular specialists to manage cholesterol levels in patients who have had a recent acute coronary syndrome or undergone a revascularization procedure.Keywords
This publication has 10 references indexed in Scilit:
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Cholesterol Lowering and the Use of Healthcare ResourcesCirculation, 1996
- Reduction in Cardiovascular Events During Pravastatin TherapyCirculation, 1995
- National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).Circulation, 1994
- Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.Circulation, 1993
- Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content.Heart, 1993
- The Value of Lowering Cholesterol after Myocardial InfarctionNew England Journal of Medicine, 1990
- Hypercholesterolemia in Elderly Persons: Resolving the Treatment DilemmaAnnals of Internal Medicine, 1990
- Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States.American Journal of Public Health, 1988
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988